{
  "insp_id": "INS-0001255985",
  "layout": "c",
  "customer_id": "505884",
  "customer_name": "Charlesson LLC",
  "customer_addr": "5301 N Beverly Drive\nOKLAHOMA CITY, OK 73105",
  "certificate": "73-R-0123",
  "site_id": "001",
  "site_name": "EYECRO LLC",
  "insp_type": "ROUTINE INSPECTION",
  "date": "04-MAR-2025",
  "report_date": "05-MAR-2025",
  "citations": [
    {
      "code": "2.31(d)(2)",
      "kind": "",
      "repeat": false,
      "desc": "Institutional Animal Care and Use Committee (IACUC)",
      "narrative": "There are deviations from the procedures described in Protocol 1, Unilateral Debridement, that were not reviewed by the\nIACUC committee:\n- The current protocol has an amendment - Appendix 4 - approved by the IACUC on 5/28/2024, which states in part: \u201cPain\nmanagement will be achieved by subcutaneous injections of buprenorphine every 6-12 hours and ketoprofen every 24h\n(at least three injections- counting the first at the start of the procedure).\u201d\nThe attending veterinarian sent an email response on 12/9/2024 which answered a question about changing the current\npain medications, stating in part: \u201cI think using Buprenorphine XR for rabbits is a good idea in this case. There\u2019s evidence\nthat it can manage mild-moderate pain in rabbits for up to 72 hours, so I recommend sticking with this dosing interval.\u201d \u201cI\nrecommend using 0.5-1mg/kg Meloxicam SC or PO every 24 hours.\u201d\nRabbit Procedure and Anesthetic Record for Rabbit #1, dated 3/3/2025, documents that at 11:13, Buprenorphine was\nadministered, and the same medication was given again approximately 24 hours later on 3/4/2025 at 10:40. When\ndiscussing this situation with facility employees, there seemed to be confusion about the appropriate dosing interval for\nthe Buprenorphine XR. Meloxicam was also administered to this rabbit rather than the original approved ketoprofen.\nThe use of Buprenorphine XR in place of Buprenorphine, and the frequency of administration for pain as recommended\nby the attending veterinarian was not submitted for approval to the IACUC. Meloxicam was not listed in the protocol\napproved medications, and was not submitted to the IACUC for review and approval.\nPrior to IACUC review, each member of the Committee shall be provided with a list of proposed activities to be reviewed.\nWritten descriptions of all proposed activities that involve the care and use of animals shall be available to all IACUC\nmembers, and any member of the IACUC may obtain, upon request, full Committee review of those activities. If full\nCommittee review is not requested, at least one member of the IACUC, designated by the chairman and qualified to\nconduct the review, shall review those activities, and shall have the authority to approve, require modifications in (to\nsecure approval), or request full Committee review of any of those activities. If full Committee review is requested for a\nproposed activity, approval of that activity may be granted only after review, at a convened meeting of a quorum of the\nIACUC, and with the approval vote of a majority of the quorum present.\nTo be corrected by March 17, 2025.\nThis inspection and exit interview were conducted with a facility representative.\nAdditional Inspectors:\nMICHAEL TYGART, VETERINARY MEDICAL OFFICER n"
    }
  ],
  "narrative": "2.31(d)(2) \n   \nInstitutional Animal Care and Use Committee (IACUC) \nThere are deviations from the procedures described in Protocol 1, Unilateral Debridement, that were not reviewed by the \nIACUC committee: \n- The current protocol has an amendment - Appendix 4 - approved by the IACUC on 5/28/2024, which states in part: \u201cPain \nmanagement will be achieved by subcutaneous injections of buprenorphine every 6-12 hours and ketoprofen every 24h \n(at least three injections- counting the first at the start of the procedure).\u201d  \n \nThe attending veterinarian sent an email response on 12/9/2024 which answered a question about changing the current \npain medications, stating in part: \u201cI think using Buprenorphine XR for rabbits is a good idea in this case. There\u2019s evidence \nthat it can manage mild-moderate pain in rabbits for up to 72 hours, so I recommend sticking with this dosing interval.\u201d \u201cI \nrecommend using 0.5-1mg/kg Meloxicam SC or PO every 24 hours.\u201d \n \nRabbit Procedure and Anesthetic Record for Rabbit #1, dated 3/3/2025, documents that at 11:13, Buprenorphine was \nadministered, and the same medication was given again approximately 24 hours later on 3/4/2025 at 10:40. When \ndiscussing this situation with facility employees, there seemed to be confusion about the appropriate dosing interval for \nthe Buprenorphine XR. Meloxicam was also administered to this rabbit rather than the original approved ketoprofen.  \n \n \nThe use of Buprenorphine XR in place of Buprenorphine, and the frequency of administration for pain as recommended \nby the attending veterinarian was not submitted for approval to the IACUC. Meloxicam was not listed in the protocol \napproved medications, and was not submitted to the IACUC for review and approval. \n \n \nPrior to IACUC review, each member of the Committee shall be provided with a list of proposed activities to be reviewed. \nWritten descriptions of all proposed activities that involve the care and use of animals shall be available to all IACUC \nmembers, and any member of the IACUC may obtain, upon request, full Committee review of those activities. If full \nCommittee review is not requested, at least one member of the IACUC, designated by the chairman and qualified to \nconduct the review, shall review those activities, and shall have the authority to approve, require modifications in (to \nsecure approval), or request full Committee review of any of those activities. If full Committee review is requested for a\n\nproposed activity, approval of that activity may be granted only after review, at a convened meeting of a quorum of the \nIACUC, and with the approval vote of a majority of the quorum present.  \n \n \nTo be corrected by March 17, 2025. \n \nThis inspection and exit interview were conducted with a facility representative. \n \nAdditional Inspectors: \nMICHAEL TYGART, VETERINARY MEDICAL OFFICER n",
  "animals_total": 3,
  "species": [
    {
      "count": 3,
      "scientific": "Oryctolagus cuniculus",
      "common": "DOMESTIC RABBIT / EUROPEAN RABBIT"
    }
  ]
}